179 related articles for article (PubMed ID: 7692715)
1. Molecular cloning of the immunodominant regions of hepatitis C virus type III and IV by immunoscreening.
Sato A; Kazami J; Arima T; Nakamura H; Kunitomo T
Acta Virol; 1993; 37(2-3):132-42. PubMed ID: 7692715
[TBL] [Abstract][Full Text] [Related]
2. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
[TBL] [Abstract][Full Text] [Related]
3. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
4. cDNA cloning of c33-c antigen gene derived from NS3 region of Chinese HCV genome, expression in Escherichia coli and development of HCV EIA second-generation diagnostic kit.
Yang YP; Liu CB; Jin DY; Zhan MY; Tang Q; Xia NS; Cao JY; Li JY
Sci China B; 1994 Feb; 37(2):190-202. PubMed ID: 7520701
[TBL] [Abstract][Full Text] [Related]
5. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
6. [Cloning and sequencing of cDNA of E2/NS1 gene of hepatitis C virus].
Shen D; Lu H; Li M; He L; Shang D; Ma X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):227-31. PubMed ID: 15617335
[TBL] [Abstract][Full Text] [Related]
7. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.
Tsutsumi M; Urashima S; Takada A; Date T; Tanaka Y
Hepatology; 1994 Feb; 19(2):265-72. PubMed ID: 7507461
[TBL] [Abstract][Full Text] [Related]
8. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
9. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
10. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies.
Cerino A; Mondelli MU
J Immunol; 1991 Oct; 147(8):2692-6. PubMed ID: 1717573
[TBL] [Abstract][Full Text] [Related]
11. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
[TBL] [Abstract][Full Text] [Related]
12. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, sequencing and expression of core and NS3 fragments of HCV from patients with HCV infection.
Tan DM; Hu GL; Arima T; Zhang Z; Nanba T; Hatanaka T
Chin Med J (Engl); 1993 Jul; 106(7):522-6. PubMed ID: 8243124
[TBL] [Abstract][Full Text] [Related]
15. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.
Ferrari C; Valli A; Galati L; Penna A; Scaccaglia P; Giuberti T; Schianchi C; Missale G; Marin MG; Fiaccadori F
Hepatology; 1994 Feb; 19(2):286-95. PubMed ID: 8294086
[TBL] [Abstract][Full Text] [Related]
16. Genomic typing of hepatitis C viruses from Korean patients: implications of genome variation in the E2/NS1 region.
Cho SH; Yoon JI; Chang JE; Ahn BM; Lee CH; Lee YI
Biochem Biophys Res Commun; 1993 Oct; 196(2):780-8. PubMed ID: 8240354
[TBL] [Abstract][Full Text] [Related]
17. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
18. [Antigenicities of groups I and II hepatitis C virus].
Kohara M
Nihon Rinsho; 1993 Feb; 51(2):338-43. PubMed ID: 7681884
[TBL] [Abstract][Full Text] [Related]
19. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
Ferns RB; Tuke PW; Sweenie CH
J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
